New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
07:05 EDTCPIXCumberland licenses Caldolor injection to Sandor for India commercialization
Cumberland announced that it has entered into an exclusive agreement with Sandor Medicaids Pvt. Ltd., an India-based pharmaceutical company, for the commercialization of Caldolor Injection in India. Under the terms of the agreement, Sandor Medicaids Pvt. Ltd. is responsible for seeking regulatory approval for Caldolor and, following approval, would handle ongoing distribution and sales in the territory. Cumberland maintains responsibility for product formulation, development and manufacturing, and will provide finished product for sale. In exchange for the license to the product, Cumberland will receive upfront and milestone payments, a transfer price and royalties on future sales of Caldolor.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
15:15 EDTCPIXCumberland says Caldador provides positive response results
Cumberland Pharmaceuticals announced that preoperative intravenous ibuprofen improved overall quality of recovery in patients undergoing laparoscopic cholecystectomy surgery. These results will be presented at the American Anesthesiology 2014 Annual Meeting in New Orleans, LA. The investigator study concluded that preoperative intravenous ibuprofen improved the overall quality of recovery including comfort, emotion and pain and reduced fatigue in the early postoperative period. Further, the study results indicated that preoperative administration of intravenous ibuprofen decreased the stress hormones catecholamines and cortisol postoperatively after laparoscopic cholecystectomy.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use